Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial
Oncology Letters · 27.07.2023 · 26 (3)
DOI: 10.3892/ol.2023.13978 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Oncology Letters, online erschienen am 27.07.2023. Verfasst von Kequan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Guiping People's Hospital, Guiping, Guangxi Zhuang Autonomous Region 537200, P.R. China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Guiping People's Hospital, Guiping, Guangxi Zhuang Autonomous Region 537200, P.R. China.
- Department of Oncology, The First People's Hospital of Nanning, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530022, P.R. China.
- Department of Oncology and Radiotherapy, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
- Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Zitieren
APA
Chen, K., Xu, G., Liang, Y., Liang, P., Gao, W., Li, Z., Liang, W., Tao, Z., Chen, J., Hu, X., & Xu, Y. (2023). Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial. Oncology Letters, 26(3). https://doi.org/10.3892/ol.2023.13978
Vancouver
Chen K, Xu G, Liang Y, Liang P, Gao W, Li Z, et al. Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial. Oncology Letters. 2023;26(3). doi:10.3892/ol.2023.13978
BibTeX
@article{Chen2023,
author = {Chen, Kequan and Xu, Guoding and Liang, Yong and Liang, Ping and Gao, Weiwei and Li, Zhou and Liang, Weichao and Tao, Zheng and Chen, Jiaxin and Hu, Xiaohua and Xu, Yaocan},
title = {Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial},
journal = {Oncology Letters},
year = {2023},
volume = {26},
number = {3},
doi = {10.3892/ol.2023.13978}
}
EUVIMED